International Business News - Myers http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Several states said Tuesday they expect multimillion-dollar payouts from drug developer Bristol-Myers Squibb Co. as part of a settlement of allegations of Medicaid fraud and illegal drug marketing practices. http://www.ibtimes.com/articles/20080715/states-claim-payout-in-bristol-myers-settlement.htm Tue, 15 Jul 2008 19:25:14 EDT The Massachusetts Medicaid program will receive more than $9 million as part of a settlement with Bristol-Myers Squibb to settle allegations of improper drug marketing and price reporting practices. http://www.ibtimes.com/articles/20080715/mass-to-get-9-2m-from-drug-marketing-settlement.htm Tue, 15 Jul 2008 13:50:27 EDT Pharmaceuticals maker Bristol-Myers Squibb Co. has agreed to spend $3.65 million to resolve federal Clean Air Act violations by eliminating ozone-depleting refrigerants at factories in six states and Puerto Rico. http://www.ibtimes.com/articles/20080708/bristol-myers-agrees-to-upgrade-cooling-equipment.htm Tue, 08 Jul 2008 15:49:39 EDT Rubber and plastics maker Myers Industries Inc. said Thursday it plans additional price increases across its business segments beginning in mid-July to offset escalating raw material and energy costs. http://www.ibtimes.com/articles/20080703/myers-industries-to-raise-prices-in-mid-july.htm Thu, 03 Jul 2008 08:57:33 EDT Among the earnings projection stories for Monday, June 30, from AP Financial News: DAYTON, Ohio (AP)--Fluid processing products maker Robbins & Myers Inc. on Monday boosted its fiscal-year profit forecast after posting fiscal third-quarter results that beat Wall Street predictions. http://www.ibtimes.com/articles/20080630/outlook-roundup-robbins-myers-sirius-satellite.htm Mon, 30 Jun 2008 14:16:44 EDT Shares of Robbins & Myers Inc. soared to a 52-week high Monday after the fluid processing products maker posted better-than-expected third-quarter results and boosted its fiscal-year profit outlook. http://www.ibtimes.com/articles/20080630/robbins-myers-shares-rise-on-3q-profit-outlook.htm Mon, 30 Jun 2008 20:02:35 EDT Fluid processing products maker Robbins & Myers Inc. on Monday boosted its fiscal-year profit forecast after posting fiscal third-quarter results that beat Wall Street predictions. http://www.ibtimes.com/articles/20080630/robbins-myers-boosts-fiscal-year-guidance.htm Mon, 30 Jun 2008 12:03:08 EDT Fluid processing products maker Robbins & Myers Inc. said Monday its fiscal third-quarter profit doubled on strong revenue and a gain related to the sale of two product lines. http://www.ibtimes.com/articles/20080630/robbins-myers-shares-rise-on-3q-profit-outlook.htm Mon, 30 Jun 2008 12:02:54 EDT Bristol-Myers Squibb completed its $234.6 million acquisition of Kosan Biosciences, the company said late Thursday. Excluding Kosan's cash balance, Bristol is paying about $190 million in cash for the company. Bristol previously said it is financing the deal with cash on hand. http://www.ibtimes.com/articles/20080627/bristol-myers-squibb-completes-kosan-acquisition.htm Fri, 27 Jun 2008 09:14:12 EDT Biopharmaceutical company Bristol-Myers Squibb Co. said Wednesday the Hart-Scott-Rodino review period for its tender offer for cancer therapy maker Kosan Biosciences Inc. has expired. http://www.ibtimes.com/articles/20080618/bristol-myers-review-period-ends-for-kosan-deal.htm Wed, 18 Jun 2008 08:42:17 EDT Biopharmaceutical company Bristol-Myers Squibb Co. spent $840,000 lobbying on drug and patent issues in the first quarter, according to a recent disclosure form. http://www.ibtimes.com/articles/20080613/bristol-myers-spent-840-000-on-lobbying-in-1q.htm Fri, 13 Jun 2008 14:48:49 EDT Biopharmaceutical company Bristol-Myers Squibb Co. said Thursday that according to a study, patients given its drug Orencia to treat a type of arthritic pain over three years did not see a worsening of the disease. http://www.ibtimes.com/articles/20080612/bristol-myers-says-drug-blocks-spread-of-arthritis.htm Thu, 12 Jun 2008 09:05:52 EDT Shares of Bristol-Myers Squibb Co. sank to their lowest level in almost six years Tuesday as analysts expressed concerns with side effects associated with the two of the company's experimental diabetes drugs. http://www.ibtimes.com/articles/20080610/bristol-shares-hit-6-year-low-on-diabetes-data.htm Tue, 10 Jun 2008 17:08:14 EDT IBM Corp. said Thursday it will provide human resources services to Bristol-Myers Squibb Co. under a 10-year, $324 million contract. The contract is part of the New York-based drugmaker's effort to control costs and streamline its organization. http://www.ibtimes.com/articles/20080605/ibm-gets-10-year-324-million-bristol-myers-pact.htm Thu, 05 Jun 2008 10:04:18 EDT Drug developer Bristol-Myers Squibb Co. reaffirmed its full-year profit guidance following the company's announcement it will by Kosan Biosciences for $5.50 per share in cash. http://www.ibtimes.com/articles/20080529/bristol-myers-reaffirms-2008-guidance.htm Thu, 29 May 2008 17:01:23 EDT Drug developer Bristol-Myers Squibb Co. said Thursday it will pay $5.50 per share in cash for cancer therapy maker Kosan Biosciences Inc., in a move to enhance its cancer treatment pipeline. http://www.ibtimes.com/articles/20080529/bristol-myers-to-buy-kosan-for-5-50-per-share.htm Thu, 29 May 2008 11:45:45 EDT Bristol-Myers Squibb Co. said Tuesday it signed a deal with KAI Pharmaceuticals to develop and sell KAI's mid-stage cardiovascular disease candidate KAI-9803. http://www.ibtimes.com/articles/20080513/bristol-myers-squibb-kai-in-development-agreement.htm Tue, 13 May 2008 10:34:34 EDT Bristol-Myers Squibb Co. and Japanese partner Otsuka Pharmaceutical Co. said Thursday federal regulators expanded approval for Abilify to aid with the treatment of bipolar disorder. http://www.ibtimes.com/articles/20080508/fda-oks-abilify-for-secondary-use-against-bipolar-disorder.htm Thu, 08 May 2008 18:27:01 EDT Bristol-Myers Squibb Co. will hold its annual stockholder meeting Tuesday and Wall Street may be looking for further updates on the company's ongoing restructuring plan. http://www.ibtimes.com/articles/20080506/ahead-of-the-bell-bristol-myers-squibb-holds-annual-meeting.htm Tue, 06 May 2008 06:24:12 EDT Drug developer Bristol-Myers Squibb Co. says it plans to sell its wound therapy unit to Nordic Capital Fund VII for $4.1 billion. The ConvaTec unit makes wound therapy and surgical care products. The deal is part of an ongoing restructuring process at Bristol-Myers that has already resulted in the sale of its medical imaging unit and plans to file an IPO to sell between 10 percent and 20 percent of its Mead Johnson Nutritional unit. http://www.ibtimes.com/articles/20080502/bristol-myers-squibb-sells-unit-for-4-1-billion.htm Fri, 02 May 2008 16:41:37 EDT